Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
diphtheria + tetanus vaccine (adult)
- Development stage
- Unknown
- Lead developer
- KEYMEN
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The Adult DT Vaccine (Diphtheria-Tetanus Vaccine) is an approved toxoid-based vaccine developed by Keymen İlaç, a subsidiary of Alagöz Holding, for the prevention of diphtheria and tetanus in adults. This vaccine is designed to elicit protective immunity against the toxins produced by *Corynebacterium diphtheriae* and *Clostridium tetani*. As a toxoid-based vaccine, it contains inactivated forms of these bacterial toxins (toxoids) that stimulate the immune system to produce neutralizing antibodies without causing the diseases themselves. Keymen İlaç has been a significant supplier of vaccines in Turkey since 1973, and this product is part of its portfolio of approved biologics used in national immunization efforts.
- Brand names
- Erişkin Tip Difteri-Tetanoz Aşısı
- Other names
- Adult DT VaccineDiphtheria-Tetanus Vaccine
Beyond the preview
Go deeper on diphtheria + tetanus vaccine (adult).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on diphtheria + tetanus vaccine (adult).